| Year |
Citation |
Score |
| 2022 |
Hatipoglu A, Menon D, Levy T, Frias MA, Foster DA. Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells. Plos One. 17: e0276579. PMID 36269753 DOI: 10.1371/journal.pone.0276579 |
0.312 |
|
| 2020 |
Uddin S, Melnyk N, Foster DA. Albumin promotes the progression of fibroblasts through late G into S-phase in the absence of growth factors. Cell Cycle (Georgetown, Tex.). 1-10. PMID 32715871 DOI: 10.1080/15384101.2020.1795999 |
0.341 |
|
| 2019 |
Frias MA, Mukhopadhyay S, Lehman E, Walasek A, Utter M, Menon D, Foster DA. Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids. The Journal of Biological Chemistry. PMID 31767684 DOI: 10.1074/Jbc.Ra119.010892 |
0.375 |
|
| 2019 |
Bernfeld E, Foster DA. Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells. Trends in Endocrinology and Metabolism: Tem. PMID 31040047 DOI: 10.1016/J.Tem.2019.03.003 |
0.355 |
|
| 2018 |
Bernfeld E, Menon D, Vaghela V, Zerin I, Faruque P, Frias MA, Foster DA. Phospholipase D-Dependent mTORC1 Activation by Glutamine. The Journal of Biological Chemistry. PMID 30194281 DOI: 10.1074/Jbc.Ra118.004972 |
0.394 |
|
| 2018 |
Utter M, Chakraborty S, Goren L, Feuser L, Zhu YS, Foster DA. Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes. Cancer Letters. PMID 29524555 DOI: 10.1016/J.Canlet.2018.03.006 |
0.31 |
|
| 2017 |
Menon D, Salloum D, Bernfeld E, Gorodetsky E, Akselrod A, Frias MA, Sudderth J, Chen PH, DeBerardinis R, Foster DA. Lipid Sensing by mTOR via de novo Synthesis of Phosphatidic Acid. The Journal of Biological Chemistry. PMID 28223357 DOI: 10.1074/Jbc.M116.772988 |
0.376 |
|
| 2016 |
Patel D, Salloum D, Saqcena M, Chatterjee A, Mroz V, Ohh M, Foster DA. A Late G1 Lipid Checkpoint that is Dysregulated in Clear Cell Renal Carcinoma Cells. The Journal of Biological Chemistry. PMID 27956548 DOI: 10.1074/Jbc.M116.757864 |
0.34 |
|
| 2016 |
Patel D, Menon D, Bernfeld E, Mroz V, Kalan S, Loayza D, Foster DA. Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells. The Journal of Biological Chemistry. PMID 26921316 DOI: 10.1074/Jbc.M115.710145 |
0.361 |
|
| 2016 |
Mukhopadhyay S, Frias MA, Chatterjee A, Yellen P, Foster DA. The Enigma of Rapamycin Dosage. Molecular Cancer Therapeutics. PMID 26916116 DOI: 10.1158/1535-7163.Mct-15-0720 |
0.37 |
|
| 2015 |
LeGendre O, Breslin PA, Foster DA. (-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization. Molecular & Cellular Oncology. 2: e1006077. PMID 26380379 DOI: 10.1080/23723556.2015.1006077 |
0.365 |
|
| 2015 |
Mukhopadhyay S, Chatterjee A, Kogan D, Patel D, Foster DA. 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells. Cell Cycle (Georgetown, Tex.). 0. PMID 26323019 DOI: 10.1080/15384101.2015.1087623 |
0.403 |
|
| 2015 |
Saqcena M, Patel D, Menon D, Mukhopadhyay S, Foster DA. Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle. Cell Cycle (Georgetown, Tex.). 1-8. PMID 25945415 DOI: 10.1080/15384101.2015.1046653 |
0.402 |
|
| 2015 |
Chatterjee A, Mukhopadhyay S, Tung K, Patel D, Foster DA. Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways. Cancer Letters. 360: 134-40. PMID 25659819 DOI: 10.1016/J.Canlet.2015.01.043 |
0.401 |
|
| 2015 |
Mukhopadhyay S, Saqcena M, Chatterjee A, Garcia A, Frias MA, Foster DA. Reciprocal regulation of AMP-activated protein kinase and phospholipase D. The Journal of Biological Chemistry. 290: 6986-93. PMID 25632961 DOI: 10.1074/Jbc.M114.622571 |
0.435 |
|
| 2015 |
Saqcena M, Mukhopadhyay S, Hosny C, Alhamed A, Chatterjee A, Foster DA. Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs. Oncogene. 34: 2672-80. PMID 25023699 DOI: 10.1038/Onc.2014.207 |
0.35 |
|
| 2014 |
Foster DA. Metabolic vulnerability of KRAS-driven cancer cells. Molecular & Cellular Oncology. 1. PMID 26609545 DOI: 10.4161/23723548.2014.963445 |
0.345 |
|
| 2014 |
Yellen P, Foster DA. Inhibition of fatty acid synthase induces pro-survival Akt and ERK signaling in K-Ras-driven cancer cells. Cancer Letters. 353: 258-63. PMID 25086185 DOI: 10.1016/J.Canlet.2014.07.027 |
0.401 |
|
| 2014 |
Foster DA, Salloum D, Menon D, Frias MA. Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR). The Journal of Biological Chemistry. 289: 22583-8. PMID 24990952 DOI: 10.1074/Jbc.R114.566091 |
0.399 |
|
| 2014 |
Legendre O, Sookdeo A, Foster DA. BxPC3 pancreatic cancer cells express a truncated Smad4 protein upon PI3K and mTOR inhibition. Oncology Letters. 7: 1165-1168. PMID 24944686 DOI: 10.3892/Ol.2014.1833 |
0.41 |
|
| 2014 |
Salloum D, Mukhopadhyay S, Tung K, Polonetskaya A, Foster DA. Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin. Molecular Cancer Therapeutics. 13: 733-41. PMID 24435447 DOI: 10.1158/1535-7163.Mct-13-0762 |
0.344 |
|
| 2013 |
Saqcena M, Menon D, Patel D, Mukhopadhyay S, Chow V, Foster DA. Amino acids and mTOR mediate distinct metabolic checkpoints in mammalian G1 cell cycle. Plos One. 8: e74157. PMID 23977397 DOI: 10.1371/Journal.Pone.0074157 |
0.357 |
|
| 2013 |
Einbond LS, Mighty J, Kashiwazaki R, Figueroa M, Jalees F, Acuna UM, Le Gendre O, Foster DA, Kennelly EJ. Garcinia benzophenones inhibit the growth of human colon cancer cells and synergize with sulindac sulfide and turmeric. Anti-Cancer Agents in Medicinal Chemistry. 13: 1540-50. PMID 23848206 DOI: 10.2174/18715206113139990095 |
0.381 |
|
| 2013 |
Foster DA. Phosphatidic acid and lipid-sensing by mTOR. Trends in Endocrinology and Metabolism: Tem. 24: 272-8. PMID 23507202 DOI: 10.1016/J.Tem.2013.02.003 |
0.348 |
|
| 2013 |
Le Gendre O, Sookdeo A, Duliepre SA, Utter M, Frias M, Foster DA. Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells. Molecular Cancer Research : McR. 11: 474-81. PMID 23443316 DOI: 10.1158/1541-7786.Mcr-12-0679 |
0.407 |
|
| 2013 |
Yellen P, Chatterjee A, Preda A, Foster DA. Inhibition of S6 kinase suppresses the apoptotic effect of eIF4E ablation by inducing TGF-β-dependent G1 cell cycle arrest. Cancer Letters. 333: 239-43. PMID 23376634 DOI: 10.1016/J.Canlet.2013.01.041 |
0.429 |
|
| 2012 |
Yellen P, Chatterjee A, Saqcena M, Salloum D, Preda A, Rodrik-Outmezguine V, Feng J, Xu L, Foster DA. Abstract 2798: Cytotoxic and cystostatic properties of rapamycin are due to differential effects on the phosphorylation of mTORC1 substrates S6 kinase and 4E-BP1 Cancer Research. 72: 2798-2798. DOI: 10.1158/1538-7445.Am2012-2798 |
0.39 |
|
| 2011 |
Yellen P, Saqcena M, Salloum D, Feng J, Preda A, Xu L, Rodrik-Outmezguine V, Foster DA. High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1. Cell Cycle (Georgetown, Tex.). 10: 3948-56. PMID 22071574 DOI: 10.4161/Cc.10.22.18124 |
0.388 |
|
| 2011 |
Xu L, Salloum D, Medlin PS, Saqcena M, Yellen P, Perrella B, Foster DA. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1). The Journal of Biological Chemistry. 286: 25477-86. PMID 21622984 DOI: 10.1074/Jbc.M111.249631 |
0.39 |
|
| 2010 |
Foster DA, Yellen P, Xu L, Saqcena M. Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s). Genes & Cancer. 1: 1124-31. PMID 21779436 DOI: 10.1177/1947601910392989 |
0.323 |
|
| 2010 |
Toschi A, Lee E, Thompson S, Gadir N, Yellen P, Drain CM, Ohh M, Foster DA. Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. Cancer Letters. 299: 72-9. PMID 20805015 DOI: 10.1016/J.Canlet.2010.08.006 |
0.391 |
|
| 2010 |
Lyo D, Xu L, Foster DA. Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway. Biochemical and Biophysical Research Communications. 396: 562-5. PMID 20438709 DOI: 10.1016/J.Bbrc.2010.04.148 |
0.399 |
|
| 2009 |
Roberts AM, Watson IR, Evans AJ, Foster DA, Irwin MS, Ohh M. Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells. Cancer Research. 69: 9056-64. PMID 19920202 DOI: 10.1158/0008-5472.Can-09-1770 |
0.333 |
|
| 2009 |
Foster DA, Toschi A. Targeting mTOR with rapamycin: one dose does not fit all. Cell Cycle (Georgetown, Tex.). 8: 1026-9. PMID 19270529 DOI: 10.4161/Cc.8.7.8044 |
0.365 |
|
| 2009 |
Foster DA. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochimica Et Biophysica Acta. 1791: 949-55. PMID 19264150 DOI: 10.1016/J.Bbalip.2009.02.009 |
0.394 |
|
| 2009 |
Toschi A, Lee E, Xu L, Garcia A, Gadir N, Foster DA. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Molecular and Cellular Biology. 29: 1411-20. PMID 19114562 DOI: 10.1128/Mcb.00782-08 |
0.402 |
|
| 2008 |
Thompson S, Chen X, Hui L, Toschi A, Foster DA, Drain CM. Low concentrations of a non-hydrolysable tetra-S-glycosylated porphyrin and low light induces apoptosis in human breast cancer cells via stress of the endoplasmic reticulum. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 7: 1415-21. PMID 18958330 DOI: 10.1039/B806536E |
0.325 |
|
| 2008 |
Garcia A, Zheng Y, Zhao C, Toschi A, Fan J, Shraibman N, Brown HA, Bar-Sagi D, Foster DA, Arbiser JL. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4267-74. PMID 18594009 DOI: 10.1158/1078-0432.Ccr-08-0102 |
0.404 |
|
| 2008 |
Toschi A, Edelstein J, Rockwell P, Ohh M, Foster DA. HIF alpha expression in VHL-deficient renal cancer cells is dependent on phospholipase D. Oncogene. 27: 2746-53. PMID 17998935 DOI: 10.1038/Sj.Onc.1210927 |
0.337 |
|
| 2008 |
Gadir N, Jackson DN, Lee E, Foster DA. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin. Oncogene. 27: 1055-62. PMID 17700525 DOI: 10.1038/Sj.Onc.1210721 |
0.368 |
|
| 2007 |
Gadir N, Lee E, Garcia A, Toschi A, Foster DA. Suppression of TGF-beta signaling by phospholipase D. Cell Cycle (Georgetown, Tex.). 6: 2840-5. PMID 18032924 DOI: 10.4161/Cc.6.22.4921 |
0.379 |
|
| 2007 |
Shi M, Zheng Y, Garcia A, Xu L, Foster DA. Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. Cancer Letters. 258: 268-75. PMID 17949898 DOI: 10.1016/J.Canlet.2007.09.003 |
0.406 |
|
| 2007 |
Mor A, Campi G, Du G, Zheng Y, Foster DA, Dustin ML, Philips MR. The lymphocyte function-associated antigen-1 receptor costimulates plasma membrane Ras via phospholipase D2. Nature Cell Biology. 9: 713-9. PMID 17486117 DOI: 10.1038/Ncb1592 |
0.323 |
|
| 2007 |
Foster DA. Regulation of mTOR by phosphatidic acid? Cancer Research. 67: 1-4. PMID 17210675 DOI: 10.1158/0008-5472.Can-06-3016 |
0.397 |
|
| 2006 |
Rodrik V, Gomes E, Hui L, Rockwell P, Foster DA. Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells. Febs Letters. 580: 5647-52. PMID 16996503 DOI: 10.1016/J.Febslet.2006.09.013 |
0.335 |
|
| 2006 |
Hui L, Zheng Y, Yan Y, Bargonetti J, Foster DA. Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene. 25: 7305-10. PMID 16785993 DOI: 10.1038/Sj.Onc.1209735 |
0.369 |
|
| 2006 |
Zheng Y, Rodrik V, Toschi A, Shi M, Hui L, Shen Y, Foster DA. Phospholipase D couples survival and migration signals in stress response of human cancer cells. The Journal of Biological Chemistry. 281: 15862-8. PMID 16595654 DOI: 10.1074/Jbc.M600660200 |
0.425 |
|
| 2006 |
Cai D, Zhong M, Wang R, Netzer WJ, Shields D, Zheng H, Sisodia SS, Foster DA, Gorelick FS, Xu H, Greengard P. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proceedings of the National Academy of Sciences of the United States of America. 103: 1936-40. PMID 16449385 DOI: 10.1073/Pnas.0510710103 |
0.354 |
|
| 2005 |
Hui L, Rodrik V, Pielak RM, Knirr S, Zheng Y, Foster DA. mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells. The Journal of Biological Chemistry. 280: 35829-35. PMID 16109716 DOI: 10.1074/Jbc.M504192200 |
0.38 |
|
| 2005 |
Rodrik V, Zheng Y, Harrow F, Chen Y, Foster DA. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc. Molecular and Cellular Biology. 25: 7917-25. PMID 16107734 DOI: 10.1128/Mcb.25.17.7917-7925.2005 |
0.376 |
|
| 2005 |
Jackson D, Zheng Y, Lyo D, Shen Y, Nakayama K, Nakayama KI, Humphries MJ, Reyland ME, Foster DA. Suppression of cell migration by protein kinase Cdelta. Oncogene. 24: 3067-72. PMID 15735725 DOI: 10.1038/Sj.Onc.1208465 |
0.409 |
|
| 2005 |
Chen Y, Rodrik V, Foster DA. Alternative phospholipase D/mTOR survival signal in human breast cancer cells. Oncogene. 24: 672-9. PMID 15580312 DOI: 10.1038/Sj.Onc.1208099 |
0.396 |
|
| 2004 |
Chen X, Hui L, Foster DA, Drain CM. Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells. Biochemistry. 43: 10918-29. PMID 15323552 DOI: 10.1021/Bi049272V |
0.347 |
|
| 2004 |
Foster DA. Targeting mTOR-mediated survival signals in anticancer therapeutic strategies. Expert Review of Anticancer Therapy. 4: 691-701. PMID 15270672 DOI: 10.1586/14737140.4.4.691 |
0.343 |
|
| 2004 |
Hui L, Abbas T, Pielak RM, Joseph T, Bargonetti J, Foster DA. Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Molecular and Cellular Biology. 24: 5677-86. PMID 15199126 DOI: 10.1128/Mcb.24.13.5677-5686.2004 |
0.404 |
|
| 2004 |
Jackson DN, Foster DA. The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 627-36. PMID 15054085 DOI: 10.1096/Fj.03-0979Rev |
0.406 |
|
| 2004 |
Abbas T, White D, Hui L, Yoshida K, Foster DA, Bargonetti J. Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta. The Journal of Biological Chemistry. 279: 9970-7. PMID 14699137 DOI: 10.1074/Jbc.M306979200 |
0.356 |
|
| 2003 |
Foster DA, Xu L. Phospholipase D in cell proliferation and cancer. Molecular Cancer Research : McR. 1: 789-800. PMID 14517341 |
0.313 |
|
| 2003 |
Chen Y, Zheng Y, Foster DA. Phospholipase D confers rapamycin resistance in human breast cancer cells. Oncogene. 22: 3937-42. PMID 12813467 DOI: 10.1038/Sj.Onc.1206565 |
0.446 |
|
| 2003 |
Zhong M, Shen Y, Zheng Y, Joseph T, Jackson D, Foster DA. Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells. Biochemical and Biophysical Research Communications. 302: 615-9. PMID 12615079 DOI: 10.1016/S0006-291X(03)00229-8 |
0.475 |
|
| 2003 |
Xu L, Frankel P, Jackson D, Rotunda T, Boshans RL, D'Souza-Schorey C, Foster DA. Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6. Molecular and Cellular Biology. 23: 645-54. PMID 12509462 DOI: 10.1128/Mcb.23.2.645-654.2003 |
0.341 |
|
| 2002 |
Zhong M, Joseph T, Jackson D, Beychenok S, Foster DA. Elevated phospholipase D activity induces apoptosis in normal rat fibroblasts. Biochemical and Biophysical Research Communications. 298: 474-7. PMID 12408976 DOI: 10.1016/S0006-291X(02)02495-6 |
0.409 |
|
| 2002 |
Shen Y, Zheng Y, Foster DA. Phospholipase D2 stimulates cell protrusion in v-Src-transformed cells. Biochemical and Biophysical Research Communications. 293: 201-6. PMID 12054584 DOI: 10.1016/S0006-291X(02)00204-8 |
0.455 |
|
| 2002 |
Joseph T, Bryant A, Frankel P, Wooden R, Kerkhoff E, Rapp UR, Foster DA. Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene. 21: 3651-8. PMID 12032867 DOI: 10.1038/Sj.Onc.1205380 |
0.432 |
|
| 2002 |
Zhong M, Lu Z, Foster DA. Downregulating PKC delta provides a PI3K/Akt-independent survival signal that overcomes apoptotic signals generated by c-Src overexpression. Oncogene. 21: 1071-8. PMID 11850824 DOI: 10.1038/Sj.Onc.1205165 |
0.419 |
|
| 2001 |
Joseph T, Wooden R, Bryant A, Zhong M, Lu Z, Foster DA. Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. Biochemical and Biophysical Research Communications. 289: 1019-24. PMID 11741292 DOI: 10.1006/Bbrc.2001.6118 |
0.448 |
|
| 2001 |
Ladeda V, Frankel P, Feig LA, Foster DA, Bal de Kier Joffe E, Aguirre-Ghiso JA. RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts. Biochemical and Biophysical Research Communications. 283: 854-61. PMID 11350063 DOI: 10.1006/Bbrc.2001.4845 |
0.372 |
|
| 2001 |
Shen Y, Xu L, Foster DA. Role for phospholipase D in receptor-mediated endocytosis. Molecular and Cellular Biology. 21: 595-602. PMID 11134345 DOI: 10.1128/Mcb.21.2.595-602.2001 |
0.363 |
|
| 2000 |
Xu L, Shen Y, Joseph T, Bryant A, Luo JQ, Frankel P, Rotunda T, Foster DA. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains. Biochemical and Biophysical Research Communications. 273: 77-83. PMID 10873567 DOI: 10.1006/Bbrc.2000.2907 |
0.43 |
|
| 2000 |
Bychenok S, Foster DA. A low molecular weight factor from dividing cells activates phospholipase D in caveolin-enriched membrane microdomains. Archives of Biochemistry and Biophysics. 377: 139-45. PMID 10775453 DOI: 10.1006/Abbi.2000.1766 |
0.39 |
|
| 2000 |
Goi T, Shipitsin M, Lu Z, Foster DA, Klinz SG, Feig LA. An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity. The Embo Journal. 19: 623-30. PMID 10675331 DOI: 10.1093/Emboj/19.4.623 |
0.389 |
|
| 2000 |
Lu Z, Hornia A, Joseph T, Sukezane T, Frankel P, Zhong M, Bychenok S, Xu L, Feig LA, Foster DA. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Molecular and Cellular Biology. 20: 462-7. PMID 10611224 DOI: 10.1128/Mcb.20.2.462-467.2000 |
0.406 |
|
| 1999 |
Hornia A, Lu Z, Sukezane T, Zhong M, Joseph T, Frankel P, Foster DA. Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. Molecular and Cellular Biology. 19: 7672-80. PMID 10523655 DOI: 10.1128/Mcb.19.11.7672 |
0.418 |
|
| 1999 |
Aguirre-Ghiso JA, Frankel P, Farias EF, Lu Z, Jiang H, Olsen A, Feig LA, de Kier Joffe EB, Foster DA. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene. 18: 4718-25. PMID 10467419 DOI: 10.1038/Sj.Onc.1202850 |
0.398 |
|
| 1999 |
Corbit KC, Foster DA, Rosner MR. Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Molecular and Cellular Biology. 19: 4209-18. PMID 10330161 DOI: 10.1128/Mcb.19.6.4209 |
0.43 |
|
| 1999 |
Frankel P, Ramos M, Flom J, Bychenok S, Joseph T, Kerkhoff E, Rapp UR, Feig LA, Foster DA. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells. Biochemical and Biophysical Research Communications. 255: 502-7. PMID 10049738 DOI: 10.1006/Bbrc.1999.0234 |
0.468 |
|
| 1998 |
Luo JQ, Liu X, Frankel P, Rotunda T, Ramos M, Flom J, Jiang H, Feig LA, Morris AJ, Kahn RA, Foster DA. Functional association between Arf and RalA in active phospholipase D complex. Proceedings of the National Academy of Sciences of the United States of America. 95: 3632-7. PMID 9520417 DOI: 10.1073/Pnas.95.7.3632 |
0.432 |
|
| 1998 |
Curto M, Frankel P, Carrero A, Foster DA. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells. Biochemical and Biophysical Research Communications. 243: 555-60. PMID 9480847 DOI: 10.1006/Bbrc.1997.7982 |
0.401 |
|
| 1998 |
Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA. Activation of protein kinase C triggers its ubiquitination and degradation. Molecular and Cellular Biology. 18: 839-45. PMID 9447980 DOI: 10.1128/Mcb.18.2.839 |
0.41 |
|
| 1997 |
Curto M, Carrero A, Frankel P, Foster DA. Activation of gene expression by a non-transforming unmyristylated-SH3-deleted mutant of Src is dependent upon Tyr-527. Biochemical and Biophysical Research Communications. 239: 681-7. PMID 9367828 DOI: 10.1006/Bbrc.1997.7510 |
0.375 |
|
| 1997 |
Luo JQ, Liu X, Hammond SM, Colley WC, Feig LA, Frohman MA, Morris AJ, Foster DA. RalA interacts directly with the Arf-responsive, PIP2-dependent phospholipase D1. Biochemical and Biophysical Research Communications. 235: 854-9. PMID 9207251 DOI: 10.1006/Bbrc.1997.6793 |
0.435 |
|
| 1997 |
Lu Z, Hornia A, Jiang YW, Zang Q, Ohno S, Foster DA. Tumor promotion by depleting cells of protein kinase C delta. Molecular and Cellular Biology. 17: 3418-28. PMID 9154841 DOI: 10.1128/Mcb.17.6.3418 |
0.417 |
|
| 1997 |
Zang Q, Lu Z, Curto M, Barile N, Shalloway D, Foster DA. Association between v-Src and protein kinase C delta in v-Src-transformed fibroblasts. The Journal of Biological Chemistry. 272: 13275-80. PMID 9148947 DOI: 10.1074/Jbc.272.20.13275 |
0.416 |
|
| 1996 |
Jiang Y, Lu Z, Zang Q, Foster DA. Regulation of phosphatidic acid phosphohydrolase by epidermal growth factor. Reduced association with the EGF receptor followed by increased association with protein kinase Cepsilon. The Journal of Biological Chemistry. 271: 29529-32. PMID 8939878 DOI: 10.1074/Jbc.271.47.29529 |
0.381 |
|
| 1996 |
Spiegel S, Foster D, Kolesnick R. Signal transduction through lipid second messengers. Current Opinion in Cell Biology. 8: 159-67. PMID 8791422 DOI: 10.1016/S0955-0674(96)80061-5 |
0.345 |
|
| 1995 |
Zang Q, Frankel P, Foster DA. Selective activation of protein kinase C isoforms by v-Src. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 6: 1367-73. PMID 8562474 |
0.31 |
|
| 1995 |
Jiang H, Lu Z, Luo JQ, Wolfman A, Foster DA. Ras mediates the activation of phospholipase D by v-Src. The Journal of Biological Chemistry. 270: 6006-9. PMID 7890731 DOI: 10.1074/Jbc.270.11.6006 |
0.43 |
|
| 1995 |
Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation Nature. 375: 577-581. PMID 7540725 DOI: 10.1038/375577A0 |
0.367 |
|
| 1995 |
Jiang H, Luo JQ, Urano T, Frankel P, Lu Z, Foster DA, Feig LA. Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature. 378: 409-12. PMID 7477381 DOI: 10.1038/378409A0 |
0.421 |
|
| 1994 |
Jiang H, Alexandropoulos K, Song J, Foster DA. Evidence that v-Src-induced phospholipase D activity is mediated by a G protein. Molecular and Cellular Biology. 14: 3676-82. PMID 8196611 DOI: 10.1128/Mcb.14.6.3676 |
0.693 |
|
| 1994 |
Jiang YW, Song J, Zang Q, Foster DA. Phosphatidylcholine-specific phospholipase D activity is elevated in v-Fps-transformed cells. Biochemical and Biophysical Research Communications. 203: 1195-2003. PMID 8093039 DOI: 10.1006/Bbrc.1994.2309 |
0.686 |
|
| 1994 |
Gupta R, Foster DA. Differential effects of protein phosphatase 2A on distinguishable intracellular signals initiated by v-Src and mediated by HaRas. Biochemical and Biophysical Research Communications. 205: 1043-50. PMID 7802630 DOI: 10.1006/Bbrc.1994.2771 |
0.379 |
|
| 1993 |
Foster DA. Intracellular signalling mediated by protein-tyrosine kinases: networking through phospholipid metabolism. Cellular Signalling. 5: 389-99. PMID 8396958 DOI: 10.1016/0898-6568(93)90078-Z |
0.37 |
|
| 1993 |
Song J, Foster DA. v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters. The Biochemical Journal. 294: 711-7. PMID 8379928 |
0.342 |
|
| 1993 |
Gupta RW, Joseph CK, Foster DA. v-Src-induced transformation is inhibited by okadaic acid. Biochemical and Biophysical Research Communications. 196: 320-7. PMID 8216307 DOI: 10.1006/Bbrc.1993.2251 |
0.406 |
|
| 1993 |
Qureshi SA, Joseph CK, Hendrickson M, Song J, Gupta R, Bruder J, Rapp U, Foster DA. A dominant negative Raf-1 mutant prevents v-Src-induced transformation. Biochemical and Biophysical Research Communications. 192: 969-75. PMID 7683468 DOI: 10.1006/Bbrc.1993.1510 |
0.665 |
|
| 1992 |
Alexandropoulos K, Qureshi SA, Rim M, Sukhatme VP, Foster DA. v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements. Nucleic Acids Research. 20: 2355-9. PMID 1594452 DOI: 10.1093/Nar/20.9.2355 |
0.35 |
|
| 1992 |
Joseph CK, Qureshi SA, Wallace DJ, Foster DA. MARCKS protein is transcriptionally down-regulated in v-Src-transformed BALB/c 3T3 cells. The Journal of Biological Chemistry. 267: 1327-30. PMID 1370466 |
0.337 |
|
| 1992 |
Alexandropoulos K, Qureshi SA, Bruder JT, Rapp U, Foster DA. The induction of Egr-1 expression by v-Fps is via a protein kinase C-independent intracellular signal that is sequentially dependent upon HaRas and Raf-1. Cell Growth & Differentiation : the Molecular Biology Journal of the American Association For Cancer Research. 3: 731-7. PMID 1332742 |
0.337 |
|
| 1992 |
Qureshi SA, Alexandropoulos K, Rim M, Joseph CK, Bruder JT, Rapp UR, Foster DA. Evidence that Ha-Ras mediates two distinguishable intracellular signals activated by v-Src. The Journal of Biological Chemistry. 267: 17635-9. PMID 1325443 |
0.31 |
|
| 1991 |
Qureshi SA, Joseph CK, Rim M, Maroney A, Foster DA. v-Src activates both protein kinase C-dependent and independent signaling pathways in murine fibroblasts. Oncogene. 6: 995-9. PMID 2067850 |
0.355 |
|
| 1991 |
Qureshi SA, Rim M, Bruder J, Kolch W, Rapp U, Sukhatme VP, Foster DA. An inhibitory mutant of c-Raf-1 blocks v-Src-induced activation of the Egr-1 promoter. The Journal of Biological Chemistry. 266: 20594-7. PMID 1939108 |
0.326 |
|
| 1991 |
Qureshi SA, Alexandropoulos K, Joseph CK, Spangler R, Foster DA. Cholera toxin induces expression of the immediate-early response gene JE via a cyclic AMP-independent signaling pathway. Molecular and Cellular Biology. 11: 102-7. PMID 1702510 DOI: 10.1128/Mcb.11.1.102 |
0.336 |
|
| 1991 |
Song JG, Pfeffer LM, Foster DA. v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine. Molecular and Cellular Biology. 11: 4903-8. PMID 1656217 DOI: 10.1128/Mcb.11.10.4903 |
0.677 |
|
| 1989 |
Spangler R, Joseph C, Qureshi SA, Berg KL, Foster DA. Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene. Proceedings of the National Academy of Sciences of the United States of America. 86: 7017-21. PMID 2550927 DOI: 10.1073/Pnas.86.18.7017 |
0.38 |
|
| 1986 |
Foster DA, Levy JB, Daley GQ, Simon MC, Hanafusa H. Isolation of chicken cellular DNA sequences with homology to the region of viral oncogenes that encodes the tyrosine kinase domain. Molecular and Cellular Biology. 6: 325-31. PMID 3023834 DOI: 10.1128/Mcb.6.1.325 |
0.512 |
|
| 1985 |
Foster DA, Shibuya M, Hanafusa H. Activation of the transformation potential of the cellular fps gene. Cell. 42: 105-15. PMID 2990723 DOI: 10.1016/S0092-8674(85)80106-9 |
0.454 |
|
| 1983 |
Foster DA, Hanafusa H. A fps gene without gag gene sequences transforms cells in culture and induces tumors in chickens. Journal of Virology. 48: 744-51. PMID 6605429 |
0.479 |
|
| 1982 |
Foster DA, Hantzopoulos P, Zubay G. Resistance of adenoviral DNA replication to aphidicolin is dependent on the 72-kilodalton DNA-binding protein. Journal of Virology. 43: 679-86. PMID 6809958 DOI: 10.1128/Jvi.43.2.679-686.1982 |
0.645 |
|
| 1981 |
Foster DA, Spangler R, Zubay G. Inhibition of host DNA synthesis by adenovirus infection is reversed at elevated temperatures. Journal of Virology. 37: 493-5. PMID 6260998 DOI: 10.1128/Jvi.37.1.493-495.1981 |
0.649 |
|
| Show low-probability matches. |
